Research and Development

The NHS alongside cancer charities are set to launch a clinical trial to investigate the effects of a cannabis-based oral …

Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …

On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …

Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …

The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …

AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …

A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …

AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …